Table 3.
Type of DRP | Group 1: ≥ 5 drugs on admission, n = 2840 drugs on admission, 391 patients % of drugs causing DRP (no. of DRPs) | Group 2: <5 drugs on admission, n = 934 drugs on admission,436 patients % of drugs causing DRP (no. of DRPs) | Difference between groups | |
---|---|---|---|---|
95% CI * | P-values† | |||
Need for additional drug | 0.2 (6) | 0.2 (2) | 0 (−0.3, 0.3) | 0.99 |
Unnecessary drug | 2.4 (69) | 1.9 (18) | 0.5 (−0.5, 1.6) | 0.37 |
Non-optimal drug | 3.4 (97) | 2.7 (25) | 0.7 (−0.5, 2.0) | 0.27 |
Non-optimal dose | 7.1 (202) | 7.1 (66) | 0.0 (−1.9, 1.9) | 0.96 |
Drug interaction | 3.4 (96) | 2.2 (21) | 1.2 (−0.0, 2.3) | 0.08 |
Need for monitoring | 3.3 (93) | 3.9 (36) | −0.6 (−2.0, 0.8) | 0.40 |
No further need for drug | 0.7 (20) | 0.8 (7) | −0.1 (−0.7, 0.6) | 0.89 |
Medical chart error | 2.7 (77) | 3.9 (36) | −1.2 (−2.5, 0.2) | 0.08 |
Therapy discussion | 1.9 (53) | 2.2 (21) | −0.3 (−1.5, 0.7) | 0.46 |
Patient adherence | 0.7 (21) | 1.3 (12) | −0.6 (−1.3, 0.2) | 0.12 |
Patient education | 1.0 (29) | 1.8 (17) | −0.8 (−1.7, 0.1) | 0.054 |
Adverse drug reaction | 1.3 (37) | 2.0 (19) | −0.7 (−1.7, 0.3) | 0.11 |
95% confidence interval for the difference between groups, given in percentage.
Significant when P < 0.05. Low numbers were found for the DRPs others: 0.2% (6) vs. 0.7% (7) in group 1 and group 2, respectively.